In essence, our results serve as a proof of principle, but generalization of the effect of choline supplementation in CF patients awaits further investigation in clinical trials addressing the effects of choline supplementation in men, women, and children and with different CFTR genotypes. The gene discussed is CFTR; the disease is cystic fibrosis.